Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort.

Autor: Bonnet F; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 1 rue Jean Burguet, 33000, Bordeaux, France. fabrice.bonnet@chu-bordeaux.fr.; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France. fabrice.bonnet@chu-bordeaux.fr.; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France. fabrice.bonnet@chu-bordeaux.fr., Le Marec F; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France., Leleux O; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France., Gerard Y; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; CH de Dax, Service de Maladies Infectieuses, 40100, Dax, France., Neau D; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; CHU de Bordeaux, Service des maladies Infectieuses et Tropicales, 33000, Bordeaux, France., Lazaro E; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 1 rue Jean Burguet, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France., Duffau P; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 1 rue Jean Burguet, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France., Caubet O; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; CH de Libourne, Service de Maladies Infectieuses, 33500, Libourne, France., Vandenhende MA; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 1 rue Jean Burguet, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France., Mercie P; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 1 rue Jean Burguet, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France., Cazanave C; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; CHU de Bordeaux, Service des maladies Infectieuses et Tropicales, 33000, Bordeaux, France., Dabis F; CHU de Bordeaux, COREVIH AQUITAINE, 33000, Bordeaux, France.; Université de Bordeaux, INSERM U1219, ISPED, 33000, Bordeaux, France.
Jazyk: angličtina
Zdroj: BMC infectious diseases [BMC Infect Dis] 2020 Nov 16; Vol. 20 (1), pp. 850. Date of Electronic Publication: 2020 Nov 16.
DOI: 10.1186/s12879-020-05593-4
Abstrakt: Background: The objective of the study was to describe the evolution of chronic non-AIDS related diseases and their risk factors, in patients living with HIV (PLHIV) in the French ANRS CO3 Aquitaine prospective cohort, observed both in 2004 and in 2014 in order to improve long-term healthcare management.
Methods: The ANRS CO3 Aquitaine cohort prospectively collects epidemiological, clinical, biological and therapeutic data on PLHIV in the French Aquitaine region. Two cross sectional analyses were performed in 2004 and 2014, to investigate the patient characteristics, HIV RNA, CD4 counts and prevalence of some common comorbidities and treatment.
Results: 2138 PLHIV (71% male, median age 52.2 years in 2014) were identified for inclusion in the study, including participants who were registered in the cohort with at least one hospital visit recorded in both 2004 and 2014. Significant increases in the prevalence of diagnosed chronic kidney disease (CKD), bone fractures, cardiovascular events (CVE), hypertension, diabetes and dyslipidaemia, as well as an increase in treatment or prevention for these conditions (statins, clopidogrel, aspirin) were observed. It was also reflected in the increase in the proportion of patients in the "high" or "very high" risk groups of the disease risk scores for CKD, CVE and bone fracture score.
Conclusions: Between 2004 and 2014, the aging PLHIV population identified in the French ANRS CO3 Aquitaine prospective cohort experienced an overall higher prevalence of non-HIV related comorbidities, including CKD and CVD. Long-term healthcare management and long-term health outcomes could be improved for PLHIV by: careful HIV management according to current recommendations with optimal selection of antiretrovirals, and early management of comorbidities through recommended lifestyle improvements and preventative measures.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje